Nimodipine: Recall - Crystallization of Fill Material
The product may no longer be bioequivalent and may potentially affect patients who are being treated for a medical emergency.
Undefined
The product may no longer be bioequivalent and may potentially affect patients who are being treated for a medical emergency.
Bolus Button may not lock in the down position when depressed and/or the orange bolus refill indicator may stay in the lowest most position, which can lead to serious adverse health consequences, including death.
Adverse effects associated with ephedrine alkaloid-containing supplements may include elevated blood pressure, rapid heartbeat, nerve damage, muscle injury, psychosis, memory loss, heart attack, stroke, seizure and death.
Recent long-term clinical pediatric trial showed children taking a high dose of Revatio had a higher risk of death than children taking a low dose.
Large variations in dosing of critical components in highly vulnerable patients could lead to serious injury and/or death.
Motor stalls could result in a termination of infusion.
Risk of the pump module door keypad overlay to separate from the keypad assembly, which could lead to a keypad malfunction.
Medical facilities should examine their inventory and immediately stop using the recalled product.
La concomitanza dell’epatopatia
Gli inibitori della tirosin chinasi sono una numerosa classe di farmaci efficaci nella terapia orale di svariate patologie neoplastiche, ematologiche e solide, usati con sempre maggior frequenza per la loro azione antiproliferativa. Questi farmaci, pur vantando una notevole efficacia, spesso si associano a eventi avversi che possono ridurre la compliance alla terapia.
80.211.154.110